Seres Therapeutics (MCRB) Metrics: History & Chart

Seres Therapeutics, Inc.(MCRB)

Biotechnology · Cambridge, MA

$2.86+0.01 (+0.35%)

Delayed quote: Oct 6, 2026, 12:34 PM EDT

About Seres Therapeutics, Inc.

Seres Therapeutics, Inc. is a pioneering microbiome therapeutics firm dedicated to engineering bacterial consortia that modulate host cells and tissues to combat various diseases. Their flagship therapeutic, SER-109, an oral microbiome treatment, has successfully concluded Phase III clinical trials for the management of Clostridioides difficile infection (CDI). The company's pipeline further encompasses SER-155, a synthetically cultured bacterial formulation currently undergoing Phase Ib evaluation. This candidate aims to mitigate the risk of gastrointestinal and bloodstream infections, alongside graft-versus-host disease, in vulnerable patients undergoing allogeneic hematopoietic stem cell or solid organ transplantation. Additionally, Seres Therapeutics is advancing SER-287 and SER-301, both in Phase Ib for ulcerative colitis, as well as SER-401, which targets metastatic melanoma, and SER-262, also directed at Clostridioides difficile infection. Seres maintains strategic alliances through licensing and collaboration agreements with entities such as Nestec Ltd. and Memorial Sloan Kettering Cancer Center. Established in 2010, the company previously operated as Seres Health, Inc. before adopting its current name in May 2015, and it maintains its principal offices in Cambridge, Massachusetts.

Cambridge, MA

66 employees

www.serestherapeutics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Richard N. Kender

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-19.03%
30D Total Return	-50.17%
YTD Total Return	-80.85%
1Y Total Return	-86.16%
3Y Total Return	-93.20%
5Y Total Return	-97.79%
10Y Total Return	-98.82%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-80.85%
2025	-10.47%
2024	-40.64%
2023	-75.00%
2022	-32.77%
2021	-66.00%
2020

CAGR TTM	-86.03%
CAGR 3Y	-59.17%
CAGR 5Y	-53.37%
CAGR 10Y	-35.85%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	11.36
PE Ratio Avg TTM	20.20
PE Ratio Avg 3Y	20.20
Current VS TTM Avg	-43.76%
Current VS 3Y Avg	-43.76%
Current VS 5Y Avg	-43.76%

All Metrics

MCRB Valuation Metrics

MCRB Stock Price Metrics

MCRB Dividend Metrics

MCRB Growth Rate Metrics

MCRB Discounted Cash Flow Metrics

MCRB Returns By Period

MCRB Yearly Returns

MCRB Average Annual Returns By Period (CAGR)

MCRB Revenue Metrics

MCRB PE Ratio Metrics

MCRB PS Ratio Metrics

MCRB PB Ratio Metrics

MCRB Price to Free Cash Flow Ratio Metrics

MCRB Debt to Equity Ratio Metrics

MCRB PEG Ratio Metrics

MCRB FCF Yield

MCRB Earnings Yield

MCRB EBITDA Yield

MCRB OCF Yield

MCRB EV/EBIT Ratio Metrics

MCRB EV/EBITDA Ratio Metrics

MCRB EV/Assets Ratio Metrics

MCRB EV/Sales Ratio Metrics

MCRB Current Ratio Metrics

MCRB Quick Ratio Metrics

MCRB ROIC Metrics

MCRB Return on Assets Metrics

MCRB Return on Equity Metrics

MCRB Net Profit Margin Metrics

MCRB Gross Profit Margin Metrics

MCRB Tax Rate Metrics

PS Ratio	14.60
PS Ratio Avg TTM	171.01
PS Ratio Avg 3Y	97.13
Current VS TTM Avg	-91.46%
Current VS 3Y Avg	-84.97%
Current VS 5Y Avg	-58.31%

PB Ratio	0.80
PB Ratio Avg TTM	2.37
PB Ratio Avg 3Y	3.60
Current VS TTM Avg	-66.28%
Current VS 3Y Avg	-77.78%
Current VS 5Y Avg	-83.81%

PFCF Ratio	76.91
PFCF Ratio Avg TTM	88.74
PFCF Ratio Avg 3Y	88.74
Current VS TTM Avg	-13.33%
Current VS 3Y Avg	-13.33%
Current VS 5Y Avg	+69.24%

Debt/Equity Ratio	1.64
Debt/Equity Ratio Avg TTM	2.23
Debt/Equity Ratio Avg 3Y	1.87
Current VS TTM Avg	-26.51%
Current VS 3Y Avg	-12.33%
Current VS 5Y Avg	+35.57%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	1.30%
FCF Yield Avg TTM	1.13%
FCF Yield Avg 3Y	1.13%
Current VS TTM Avg	+15.56%
Current VS 3Y Avg	+15.56%
Current VS 5Y Avg	-58.07%

Earnings Yield	8.80%
Earnings Yield Avg TTM	5.54%
Earnings Yield Avg 3Y	5.54%
Current VS TTM Avg	+58.78%
Current VS 3Y Avg	+58.78%
Current VS 5Y Avg	+58.78%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.67
Ev/Assets Ratio Avg TTM	1.01
Ev/Assets Ratio Avg 3Y	0.86
Current VS TTM Avg	-33.92%
Current VS 3Y Avg	-21.68%
Current VS 5Y Avg	-42.85%

Ev/Sales Ratio	36.40
Ev/Sales Ratio Avg TTM	235.31
Ev/Sales Ratio Avg 3Y	121.89
Current VS TTM Avg	-84.53%
Current VS 3Y Avg	-70.14%
Current VS 5Y Avg	-16.36%

Current Ratio	2.11
Current Ratio Avg TTM	2.04
Current Ratio Avg 3Y	1.93
Current VS TTM Avg	+3.77%
Current VS 3Y Avg	+9.39%
Current VS 5Y Avg	-9.90%

Quick Ratio	2.11
Quick Ratio Avg TTM	2.04
Quick Ratio Avg 3Y	1.82
Current VS TTM Avg	+3.77%
Current VS 3Y Avg	+16.43%
Current VS 5Y Avg	-7.04%

ROIC	(103.04%)
ROIC Avg 3Y	(75.92%)
ROIC Avg 5Y	(70.96%)
Current VS 3Y Avg	-35.71%
Current VS 5Y Avg	-45.20%
Current VS 10Y Avg	-41.68%

ROA	(22.11%)
ROA Avg TTM	(6.32%)
ROA Avg 3Y	(4.83%)
Current VS TTM Avg	-249.77%
Current VS 3Y Avg	-358.05%
Current VS 5Y Avg	-146.45%

ROE	(65.05%)
ROE Avg TTM	8.82%
ROE Avg 3Y	(66.14%)
Current VS TTM Avg	-837.63%
Current VS 3Y Avg	+1.65%
Current VS 5Y Avg	+5.64%

Net Profit Margin	(1192.94%)
Net Profit Margin Avg TTM	(1220.74%)
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	+2.28%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	+11.25%

Gross Profit Margin	(423.83%)
Gross Pft Margin Avg TTM	(94.06%)
Gross Pft Margin Avg 3Y	26.30%
Current VS TTM Avg	-350.58%
Current VS 3Y Avg	-1711.51%
Current VS 5Y Avg	-229.29%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A